RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis
Elhaw, A. T.; Tang, P. W.; Cheng, Y.-Y.; Kamlapurkar, S.; Javed, Z.; Al-Saad, S.; White, S. R.; Abdelnaby, A. E.; Khan, H.; Choi, A. S.; Cole, A. R.; Kim, Y.-S.; Atiya, H. I.; Trebak, M.; Zervantonakis, I. K.; Buckanovich, R. J.; Aird, K. M.; Coffman, L. G.; Mythreye, K.; Hempel, N.
Show abstract
All ovarian cancer subtypes spread via transcoelomic metastasis, where cells disseminate into the peritoneal fluid, resist anoikis, and form multicellular aggregates that invade the peritoneum. This represents the main driver of morbidity and mortality for peritoneal cancer patients. Mechanisms necessary for cancer cells to survive matrix detachment and initiate transcoelomic metastasis remain poorly defined. To address this, we identified a conserved detachment-sensitive gene signature activated shortly after matrix-detachment across multiple ascites-derived cancer cell lines. RHOV, an atypical, constitutively active and understudied member of the Rho GTPase family, emerged as a top upregulated transcript, which was confirmed in patient ascites-derived tumor cells. Functionally, loss of RHOV impairs anoikis resistance, multicellular aggregate integrity, migration and invasion, and completely abolishes transcoelomic tumor progression in vivo. RHOV enhances c-Jun signaling and cytoskeletal remodeling, which is dependent on both RHOV GTP-binding and membrane localization. These findings define RHOV as a novel detachment-sensitive Rho GTPase and establish RHOV as a critical regulator of peritoneal metastasis for the first time.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Weakly migratory metastatic breast cancer cells activate fibroblasts via microvesicle-Tg2 to facilitate dissemination and metastasis 96%
- KSR1-and ERK-dependent Translational Regulation of the Epithelial-to-Mesenchymal Transition 95%
- Limited inhibition of multiple nodes in a driver network blocks metastasis 95%
Similar papers in this journal
- Ki-67 promotes sequential stages of tumourigenesis by enabling cellular plasticity 95%
- SOS1 and KSR1 modulate MEK inhibitor responsiveness to target resistant cell populations based on PI3K and KRAS mutation status 94%
- A Targeted Combination Therapy Achieves Effective Pancreatic Cancer Regression And Prevents Tumor Resistance 94%
Similar papers in this journal
- Vimentin is Required for Tumor Progression and Metastasis in a Mouse Model of Non-Small Cell Lung Cancer 95%
- Isoform-specific functions of Numb in breast cancer progression, metastasis and proteome remodeling. 95%
- Oncogenic RAS sensitizes cells to drug-induced replication stress via transcriptional silencing of P53 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.